A triple-action cancer jab blocked a crucial protein that helps cancers grow and stopped a second pathway that tumour cells use to evade treatment, while also activating the immune system to attack — with 15 patients seeing their tumours completely disappear in the trial.

Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy

A promising triple-action cancer jab being trialled at the Royal Marsden has shown encouraging results for some patients with head and neck cancer, with tumours disappearing…

The effectiveness of amivantamab is being evaluated in around 60 clinical trials worldwide.

LONDON, May 31 — Doctors have reported striking results from an international trial of a triple action cancer jab that eliminated tumours in some patients.According to The...

A triple-action cancer jab blocked a crucial protein that helps cancers grow and stopped a second pathway that tumour cells use to evade treatment, while also activating the…

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

A new experimental cancer treatment is generating significant excitement among oncologists after clinical trial results showed it can dramatically shrink tumors and, in some…

A groundbreaking trial across 11 countries reveals a triple-action cancer jab can completely eradicate tumours in patients with advanced, treatment-resistant cancers.